Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals, page-57

Vaxinia Trial - Interim Results - November 6 2023

Sensational. This is ridiculously good. Basically unheard of given the relatively low levels of Vaxinia dosed and the advanced stage of cancer in those patients presenting to the trial. Wow. Can you imagine the results at 10 parts to the 8? Keep in mind the virus is still active in those exhibiting disease stabilisation, with stabilisation defined as radiological evidence of no change or continuous decrease in size of the tumor for six months or more. They themselves may be in a position to achieve partial if not complete responses, particularly if additional doses of Vaxinia are administered to them.

This loos like its evolving into Nobel Prize worthy territory for Professor Yuman Fong. So proud of him. And now we await the ratcheting up of Vaxinia doses, climbing up the therapeutic window, to deliver even more outstanding results. This is seriously next level. Remember it's all in SOLID TUMOURS. 86% positive treatment effect rates, man I've seen drugs deemed successful with the inverse (i.e., 14%).

Way to go IMU. You may not reach the $1 I predicted in 2023, but you bloody well should!

DYOR Seek investment advice as and when required Opinions only